增强效力的同源抗体药物偶联物载药系统
Homocamptothecin Payloads with Enhanced Potency for Antibody-Drug Conjugates
Xie Jiajun, Li Yalong, Pan Fengyuan, Wang Yifan, Lu Wei, Wang Bo, Zhu Shulei, Zhang Juan
Journal:JOURNAL OF MEDICINAL CHEMISTRY
IF:7.3
DOI:10.1021/acs.jmedchem.6c00397
PMID:
Published:2026-08-17
research field:分子生物学细胞生物学生物医学工程纳米技术
Abstract
Camptothecin derivatives, exemplified by DXd, are a dominant class of payloads for antibody-drug conjugates (ADCs). Herein, we describe the design and synthesis of H2 , a novel homocamptothecin featuring a simplified hydroxybutyl structure that circumvents the complex assembly of the F-ring. H2 exhibits superior hydrolytic stability, while maintaining potent intrinsic cytotoxicity. In vitro, the H2 -conjugated ADC candidates, Tras-L-H2 and Tras-TL-H2 , demonstrated robust bystander killing effect and potent antiproliferative activity, similar to that observed with T-DXd. Importantly, these candidates exhibited noninferior antitumor efficacy to that of T-DXd in JIMT-1 xenograft model. These findings demonstrate the therapeutic utility of the seven-membered homocamptothecin scaffold and identify H2 as a promising candidate for next-generation ADC payloads.
本文使用的Yeasen产品
南美超级胎牛血清999尝鲜特惠


